From owner-diagnost@hgmp.mrc.ac.uk Wed Apr 27 09:14:45 2005 Return-Path: X-Original-To: diagnost-outgoing Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with SMTP id 5AE59519A9 for ; Wed, 27 Apr 2005 09:14:45 +0100 (BST) X-Original-To: diagnost-list@hgmp.mrc.ac.uk Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id F3F9851999 for ; Wed, 27 Apr 2005 09:14:44 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6045) id 10BE3519A6; Wed, 27 Apr 2005 09:14:42 +0100 (BST) X-Original-To: bionet-diagnostics@net.bio.net Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1D6BF5196B for ; Wed, 23 Feb 2005 19:49:56 +0000 (GMT) Received: from chx400.switch.ch (chx400.switch.ch [130.59.10.2]) (using TLSv1 with cipher EDH-RSA-DES-CBC3-SHA (168/168 bits)) (No client certificate requested) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 4515E51944 for ; Wed, 23 Feb 2005 19:49:55 +0000 (GMT) Received: from shawidc-mo1.cg.shawcable.net ([24.71.223.10] helo=pd3mo2so.prod.shaw.ca) by chx400.switch.ch with esmtp (Exim 3.20 #1) id 1D41iv-0000x7-00 for bionet-diagnostics@moderators.isc.org; Wed, 23 Feb 2005 19:59:01 +0100 Received: from pd3mr1so.prod.shaw.ca (pd3mr1so-qfe3.prod.shaw.ca [10.0.141.177]) by l-daemon (Sun ONE Messaging Server 6.0 HotFix 1.01 (built Mar 15 2004)) with ESMTP id <0ICD006OEOQ7JJC0@l-daemon> for bionet-diagnostics@moderators.isc.org; Wed, 23 Feb 2005 11:58:55 -0700 (MST) Received: from pd2pm1so ([10.0.122.154]) by pd3mr1so.prod.shaw.ca (Sun ONE Messaging Server 6.0 HotFix 1.01 (built Mar 15 2004)) with ESMTP id <0ICD00079OQ7ES70@pd3mr1so.prod.shaw.ca> for bionet-diagnostics@moderators.isc.org; Wed, 23 Feb 2005 11:58:55 -0700 (MST) Received: from shaw.ca ([10.0.146.66]) by l-daemon (iPlanet Messaging Server 5.0 Patch 2 (built Dec 14 2000)) with ESMTP id <0ICD00929OPQIX@l-daemon> for bionet-diagnostics@moderators.isc.org; Wed, 23 Feb 2005 11:58:38 -0700 (MST) Received: by shaw.ca (8.12.8+Sun/8.12.8/Submit) id j1NIwcVM018037; Wed, 23 Feb 2005 11:58:38 -0700 (MST) X-Trace: pd7tw2no 1109185118 64.59.144.75 (Wed, 23 Feb 2005 11:58:38 MST) From: test Subject: test To: bionet-diagnostics@moderators.isc.org Message-id: Organization: Shaw Residential Internet X-Complaints-to: abuse@shaw.ca Content-type: text/html NNTP-posting-date: Wed, 23 Feb 2005 11:58:38 MST X-Trace-PostClient-IP: 70.71.3.235 Newsgroups: bionet.diagnostics X-Newsreader: BNews2004v20 Date: Wed, 27 Apr 2005 09:14:42 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk

test

From owner-diagnost@hgmp.mrc.ac.uk Wed Apr 27 09:16:22 2005 Return-Path: X-Original-To: diagnost-outgoing Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with SMTP id 8005E5199B for ; Wed, 27 Apr 2005 09:16:22 +0100 (BST) X-Original-To: diagnost-list@hgmp.mrc.ac.uk Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 4074551999 for ; Wed, 27 Apr 2005 09:16:22 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6045) id E5A3D519AA; Wed, 27 Apr 2005 09:16:13 +0100 (BST) X-Original-To: bionet-diagnostics@net.bio.net Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 86DEE519C4 for ; Mon, 21 Mar 2005 17:26:21 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id C0457519E7; Mon, 21 Mar 2005 17:26:17 +0000 (GMT) To: bionet-diagnostics@net.bio.net From: invite@ahead-bs.com (BMA11) Newsgroups: bionet.diagnostics Subject: BioMedAHead - Biotechnology, Drugs and Medical Device Exhibition Organization: BMA11 Message-ID: <200503211726.j2LHQDm28951@ahead-bs.ahead-bs.com> MIME-Version: 1.0 Content-type: text/html; charset=iso-8859-1 Content-Transfer-Encoding: binary Content-Disposition: inline X-Original-To: diagnost@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9C765519D9 for ; Mon, 21 Mar 2005 17:26:16 +0000 (GMT) X-Received: from ahead-bs.ahead-bs.com (ahead-bs.ahead-bs.com [216.71.84.203]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id AE5135195D for ; Mon, 21 Mar 2005 17:26:14 +0000 (GMT) X-Received: (from ahead-bs@localhost) by ahead-bs.ahead-bs.com (8.11.6/8.11.6) id j2LHQDm28951; Mon, 21 Mar 2005 11:26:13 -0600 X-To: diagnost@net.bio.net X-Reply-To: BMA11 X-List: bma11 X-List-Archive: http://ahead-bs.com/cgi-bin/mojo/mojo.cgi?f=archive&l=bma11 X-List-ID: 20050321100726 X-List-Owner: X-List-Subscribe: http://ahead-bs.com/cgi-bin/mojo/mojo.cgi?f=s&l=bma%31%31 X-List-Unsubscribe: http://ahead-bs.com/cgi-bin/mojo/mojo.cgi?f=u&l=bma%31%31 X-List-URL: http://ahead-bs.com/cgi-bin/mojo/mojo.cgi?l=bma11 X-List-Software: Mojo Mail 2.8.7 X-Precedence: list X-Priority: 3 Date: Wed, 27 Apr 2005 09:16:13 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk

Become an Exhibitor

In cooperation with Bio-Tech 2005 – Conference & Exhibition

International BioMedAHead Virtual Exhibition

BioMedAHead is the first-ever Biotechnology & Medical Device Exhibition on the Internet. It is scheduled to make its worldwide debut May 1^st , 2005 for a period of four months till Aug 31^st , 2005, open 24 hours a day 7 days a week.

The Internet Drugs, Biotechnology & Medical Device exhibition is expected to host 250 companies from all over the world which will exhibit the main aspects in Biotechnology and Medical Device.

Biotechnology Drugs Medical Device

Agriculture / Analytical Chemistry / Biochemistry / Biologics / Bioinformatics and Chemo informatics / Clinical Trials & Pre Clinical Trials / Cosmetics / Diagnostics / Education / Environmental Control / Food Industry / Health Care / Hospitals / Incubators / Information management / Laboratories / Manufacturers / Medical Centers / Medicinal Products / Pharmaceuticals / Quality Assurance & Quality Control / Research and Development / Safety / Start Up / Veterinary / and more...

Related fields: Patents, Venture capitals, Regulation, Computers, Software & Hardware, Investors, Consultants, Strategic Partners

BioMedAHead’s forecast: half a million people from all over the world, mainly Biotechnology and Medical professionals, will "visit" the exhibition.

This virtual exhibition is designed to look like a conventional exhibition, exhibitors present their goods, products and know how, communicate and relate with the exhibition visitors and even take part in conferences, seminars and discussions that are to be held during the exhibition. The exhibition’s innovative interface is user friendly thus enabling both visitors and exhibitors to visit all booths, and enjoy the virtual exhibition as a realistic experience.

For more information link to: http://www.ahead-bs.com
For our exhibition site: http://www.biomedahead.com
For registration link to: info@ahead-bs.com

To unsubscribe from: BMA11, just follow this link:

http://ahead-bs.com/cgi-bin/mojo/mojo.cgi?f=u&l=bma%31%31&e=diagnost@net.bio.net&p=6817

Click this link, or copy and paste the address into your browser.

--- From owner-diagnost@hgmp.mrc.ac.uk Wed Apr 27 09:17:44 2005 Return-Path: X-Original-To: diagnost-outgoing Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with SMTP id 127B7519AB for ; Wed, 27 Apr 2005 09:17:44 +0100 (BST) X-Original-To: diagnost-list@hgmp.mrc.ac.uk Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id C6BD85199A for ; Wed, 27 Apr 2005 09:17:43 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6045) id 77AAD519AB; Wed, 27 Apr 2005 09:17:41 +0100 (BST) Newsgroups: bionet.diagnostics Message-Id: <20050427081741.77AAD519AB@mercury.hgmp.mrc.ac.uk> Date: Wed, 27 Apr 2005 09:17:41 +0100 (BST) From: mod-diag@hgmp.mrc.ac.uk (bionet.diagnostics moderator) To: undisclosed-recipients:; Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk post From: "Health" Newsgroups: bionet.diagnostics Subject: World First Cancer Immune Booster Message-ID: <425b4445$0$10822$afc38c87@news.optusnet.com.au> X-Trace: 1113277509 10822 211.31.57.232 Most people with Cancer or AIDS have no immune system left. We've developed a world first "natural immune booster" which helps people fight their disease. Our totally natural product comes from the fresh Arctic Ocean. www.protecura.com From owner-diagnost@hgmp.mrc.ac.uk Wed Apr 27 10:00:49 2005 Return-Path: X-Original-To: diagnost-outgoing Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with SMTP id 2319B519D2 for ; Wed, 27 Apr 2005 10:00:49 +0100 (BST) X-Original-To: diagnost-list@hgmp.mrc.ac.uk Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id DAFFF519D3 for ; Wed, 27 Apr 2005 10:00:48 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6045) id 0722E519D2; Wed, 27 Apr 2005 10:00:46 +0100 (BST) X-Original-To: bionet-diagnostics@net.bio.net Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id BADD47D11D for ; Fri, 31 Dec 2004 01:30:36 +0000 (GMT) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6022) id 87B457D0C3; Fri, 31 Dec 2004 01:30:32 +0000 (GMT) To: bionet-diagnostics@net.bio.net From: editor@gene-quantification.info (editor@gene-quantification.info) Newsgroups: sci.bio.misc,sci.med.diseases.hepatitis,bionet.diagnostics,sci.med.prostate.prostatitis Subject: qPCR Symposium Agenda NOW online Organization: http://groups.google.com Message-ID: X-Original-To: bionet-announce@net.bio.net Content-Type: text/plain; charset=ISO-8859-1 Content-Transfer-Encoding: 8bit X-Spamscanner: mailbox8.ucsd.edu (v1.5 Dec 3 2004 17:34:44, -2.3/5.0 3.0.0) X-MailScanner: PASSED (v1.2.8 19856 iBTLtsT8020124 mailbox8.ucsd.edu) Date: Wed, 27 Apr 2005 10:00:46 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk qPCR Satellite Symposium at the BioCity Leipzig Deutscher Platz 5, 04103 Leipzig, Germany http://leipzig05.gene-quantification.info/ organized by Dr. Michael W. Pfaffl and powered by http://www.BioScience-Events.com The main focus of the qPCR symposium is related to the key problems in real-time PCR. Optimisation, Normalisation & Standardisation Download the agenda http://www.bioscience-events.com/leipzig/agenda-qPCR-symposium.pdf Leading academic researchers and industrial contributors in the field will participate in the symposium, which will be an arena for fruitful discussions between researchers of different backgrounds. The Symposium offers an overview of the present knowledge and future developments in qPCR technology and its wide applications. The main focus of the talks will be on Optimisation, Normalisation and Standardisation of the real-time PCR and RT-PCR reaction. Starting from the pitfalls in tissue preparation, RNA or DNA extraction, we have a further focus on the cDNA synthesis (RT), and how to optimize the PCR reaction itself. Next key points in qPCR are the post qPCR working steps: how to determine the right Ct, which quantification strategy is the right one and how to calculate with the generated Ct data, BioInformatics (HKGs, normalisation...), to come to a biological meaningful results. Session 1: Pre-analytical steps (Moderator: M. W. Pfaffl) Session 2: Single cell PCR (Moderator: M. Kubista) Session 3: Probes Technologies (Moderator: S. Bustin) Session 4: Quantification strategies & Optimization (Moderator: S. Bustin) Session 5: Applications Moderator: (N. Zoric) Session 6: Post PCR & Bioinformatics (Moderator: M. W. Pfaffl)